Ingevity (NGVT) Asset Writedowns and Impairment (2016 - 2026)

Ingevity (NGVT) has reported Asset Writedowns and Impairment for 9 consecutive years, with $32.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Asset Writedowns and Impairment changed N/A year-over-year to $32.1 million; the TTM figure through Jun 2026 stood at $150.7 million (up 1983.75% YoY), while the FY2025 annual figure was $109.3 million, up 1984.48% from the prior year.
• Asset Writedowns and Impairment grew to $32.1 million in Q2 2026 per NGVT's latest filing, from $2.8 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $117.8 million in Q4 2025 and bottomed at -$91.1 million in Q4 2023.
• Historically, Asset Writedowns and Impairment has averaged $8.4 million across 5 years, with a median of $2.8 million in 2026.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment sank 12914.29% — and 2026, when it surged 2900.0%.
• Ingevity's Asset Writedowns and Impairment stood at -$700000.0 in 2022, then tumbled by 12914.29% to -$91.1 million in 2023, then surged by 94.95% to -$4.6 million in 2024, then jumped by 2660.87% to $117.8 million in 2025, then tumbled by 72.75% to $32.1 million in 2026.
• Business Quant data shows NGVT's Asset Writedowns and Impairment at $32.1 million in Q2 2026, $2.8 million in Q1 2026, and $117.8 million in Q4 2025.